Skip to nav Skip to content


March 6, 2019


IDSA & ID in the News

Infectious Disease News spoke with IDSA spokesperson Matthew Zahn, MD, FIDSA to get his perspective on findings from a recent study published in IDSA’s Clinical Infectious Diseases which reports that “early treatment with oseltamivir was associated with a 30% lower mortality rate compared with later treatment in patients with influenza A(H3N2) during eight recent influenza seasons in Greece.”

This is just one of the several news pieces that IDSA and our member spokespersons contributed to, in addition to others highlighted below. Follow us on TwitterLinkedIn and Facebook to see the latest news stories featuring IDSA, HIVMA and our members.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.